Skip to nav Skip to content

IDSA Media Briefing: Scientific and Economic Impacts of HIV Research Funding Delays

Experts in infectious diseases will discuss how delays in—and the potential withholding of—federal funding for the HIV/AIDS Clinical Trials Networks could impact scientific progress.
 

  • Benefits of and breakthroughs made through the National Institutes of Health’s HIV/AIDS Clinical Trials Network
  • Long-term impact of reduced clinical research capacity on the treatment and prevention of HIV
  • Consequences of delayed research funding notices on institutions and communities
Details
Date September 18, 2026
Time 9:00 AM
Virtual
Video
Advertisement
Speakers and Hosts

Speakers

  • Carlos Malvestutto, MD, MPH, FIDSA

    Carlos Malvestutto, MD, MPH, FIDSA

    The Ohio State University
    Board Director, HIV Medicine Association
    Clinical Research Site Leader, Infectious Disease Clinical Trials

  • Aadia Rana, MD, FIDSA

    Aadia Rana, MD, FIDSA

    University of Alabama at Birmingham
    Fellow, Infectious Diseases Society of America
    Director, Implementation and Community Sciences Core, Center for AIDS Research

  • Jeanne Marrazzo, MD, MPH, FIDSA

    Jeanne Marrazzo, MD, MPH, FIDSA

    (Moderator)
    Chief Executive Officer, Infectious Diseases Society of America